Tag: Gennova
Post DCGI approval, Gennova to produce 40-50 lakh doses of GEMCOVAC-19...
To be sold under the brand name GEMCOVAC™-19, the two dose vaccine will be available for adults above 18 years of age and administered intramuscularly at 28 days apart
COVID-19: India’s own mRNA vaccine set to begin human clinical trials
Indigenous mRNA vaccine candidate supported by Department of Biotechnology has got Drug Controller nod to initiate Human clinical trials........................
DBT seed funds Gennova’s novel mRNA based COVID-19 vaccine, HGCO19
Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under Ind CEPI, implemented by BIRAC will soon move into clinical trials...............